Abstract
Lisinopril an ACE inhibitor when administered to pregnant mice was found to be teratogenic. Chrysanthemum indicum extract was also administered to pregnant mice and compared with the teratogenic effect with those produced by lisinopril. Thirteen pregnantfemale mice were administered lisinopril orally in the dose of 2mg/100g and Guldaudi extract 50mg/100g body weight of mice. Lisinopril and Guldaudi were administered to pregnant mice daily from day zero of pregnancy. On day 18 mother mice was sacrificed and pups were collected. These, showed significant stunting in size (p<0.001) in both lisinopril and guldaudi groups. Exencephaly was found in 26.08% in lisinopril group; however hypoplasia of skull was present in Guldaudi group. Resorption (5%) was noticed only in Guldaudi group. The lisinopril in dose of 2mg/100g body weight tried was found to be teratogenic and dose of Guldaudi extract in the dose of 50mg/100g was also found teratogenic with less severity as compared to 2 mg dose of lisinopril. Oligohydramnios and hypoxia following lisinopril and Guldaudi administration was attributed to be the cause of these malformations.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.